Product Pathways - Cytoskeletal Signaling
Myosin Light Chain 2 Antibody #3672
| Applications | Reactivity | Sensitivity | MW (kDa) | Source |
|---|---|---|---|---|
| W | H M R (Pg) (C) (B) | Endogenous | 18 | Rabbit |
Applications Key:
W=Western Blotting
Reactivity Key:
H=Human
M=Mouse
R=Rat
Pg=Pig
C=Chicken
B=Bovine
Species cross-reactivity is determined by Western blot.
Specificity / Sensitivity
Myosin Light Chain 2 Antibody detects endogenous levels of total Myosin Light Chain 2 (smooth muscle). This antibody does not cross-react with the cardiac isoform of Myosin Light Chain 2, or Myosin Essential Light Chain.
Source / Purification
Polyclonal antibodies are produced by immunizing rabbits with a synthetic peptide (KLH-coupled) corresponding to amino-terminal residues of human Myosin Light Chain 2 (smooth muscle isoform). Antibodies are purified by protein A and peptide affinity chromatography.
Western Blotting
Western blot analysis of extracts from HEK293, PL45, A431, C2C12 and C6 cells, using Myosin Light Chain 2 Antibody.
Background
Myosin is composed of six polypeptide chains: two identical heavy chains and two pairs of light chains. Myosin light chain 2 (MLC2), also known as myosin regulatory light chain (MRLC or RLC, LC20), has many isoforms depending on its distribution. In smooth muscle, MLC2 is phosphorylated at Thr18 and Ser19 by myosin light chain kinase (MLCK) in a Ca2+/calmodulin-dependent manner (1). This phosphorylation is correlated with myosin ATPase activity and smooth muscle contraction (2). ROCK also phosphorylates Ser19 of smooth muscle MLC2, which regulates the assembly of stress fibers (3). Phosphorylation of smooth muscle MLC2 at Ser1/Ser2 and Ser9 by PKC and cdc2 has been reported to inhibit myosin ATPase activity (4,5). Phosphorylation by cdc2 controls the timing of cytokinesis (5). Transgenic mice lacking phosphorylation sites on the cardiac muscle isoform show morphological and functional abnormalities (6).
- Ikebe, M. and Hartshorne, D.J. (1985) J. Biol. Chem. 260, 10027-10031.
- Tan, J. L. et al. (1992) Annu. Rev. Biochem. 61, 721-759.
- Totsukawa, G. et al. (2000) J. Cell Biol. 150, 797-806.
- Ikebe, M. et al. (2000) J. Biol. Chem. 262, 9569-9573.
- Satterwhite, L. L. et al. (1992) J. Cell Biol. 118, 595-605.
- Sanbe, A. et al. (1999) J. Biol. Chem. 274, 21085-21094.
Application References
- Watanabe, T. et al. (2007) Mol Biol Cell 18, 605-16. This article references the use of Myosin Light Chain 2 Antibody in the following applications: Western Blotting
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
Companion Products
- 3671 Phospho-Myosin Light Chain 2 (Ser19) Antibody
- 3674 Phospho-Myosin Light Chain 2 (Thr18/Ser19) Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
- 3675 Phospho-Myosin Light Chain 2 (Ser19) Mouse mAb
This product is for in vitro research use only and is not intended for use in humans or animals. This product is not intended for use as therapeutic or in diagnostic procedures.
